111 related articles for article (PubMed ID: 2053787)
1. Evaluation of a pen injector system for growth hormone treatment.
Gluckman PD; Cutfield WS
Arch Dis Child; 1991 Jun; 66(6):686-8. PubMed ID: 2053787
[TBL] [Abstract][Full Text] [Related]
2. Optimum method for administration of biosynthetic human growth hormone: a randomised crossover trial of an Auto Injector and a pen injection system.
Stanhope R; Albanese A; Moyle L; Hamill G
Arch Dis Child; 1992 Aug; 67(8):994-7. PubMed ID: 1520018
[TBL] [Abstract][Full Text] [Related]
3. Patient acceptance of Nordiject: a new drug delivery system for growth hormone.
Jørgensen JT; Mortensen HB; Jørgensen JO
DICP; 1991 Jun; 25(6):585-8. PubMed ID: 1877265
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone therapy with a new delivery system.
Jørgensen JT; Susgaard S
Indian J Pediatr; 1991; 58 Suppl 1():43-50. PubMed ID: 1824374
[TBL] [Abstract][Full Text] [Related]
5. Patient evaluation of a new injection pen for growth hormone treatment in children and adults.
Sjöblom K; Albertsson-Wikland K; Bengtsson BA; Johannsson G; Thorén M; Degerblad M; Savage MO
Acta Paediatr Suppl; 1995 Sep; 411():63-5. PubMed ID: 8563072
[TBL] [Abstract][Full Text] [Related]
6. Simplified growth hormone therapy--first clinical experience with the KabiPen.
Albertsson-Wikland K
Acta Paediatr Scand Suppl; 1988; 343():103-6. PubMed ID: 3057801
[TBL] [Abstract][Full Text] [Related]
7. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial.
Kivitz A; Cohen S; Dowd JE; Edwards W; Thakker S; Wellborne FR; Renz CL; Segurado OG
Clin Ther; 2006 Oct; 28(10):1619-29. PubMed ID: 17157117
[TBL] [Abstract][Full Text] [Related]
8. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
[TBL] [Abstract][Full Text] [Related]
9. Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial.
McAllister L; Anderson J; Werth K; Cho I; Copeland K; Le Cam Bouveret N; Plant D; Mendelman PM; Cobb DK
Lancet; 2014 Aug; 384(9944):674-81. PubMed ID: 24881803
[TBL] [Abstract][Full Text] [Related]
10. The recombinant human chorionic gonadotropin prefilled pen: results of patient and nurse human factors usability testing.
Saunders H; Schertz JC; Hecker C; Lang B; Arriagada P
Expert Opin Drug Deliv; 2012 Aug; 9(8):893-900. PubMed ID: 22703331
[TBL] [Abstract][Full Text] [Related]
11. Improvement of patient convenience in treatment with growth hormone.
Jørgensen JT
J Pediatr Endocrinol; 1994; 7(2):175-80. PubMed ID: 8061763
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of oral liquid measuring devices: comparison of dosing cup and oral dosing syringe.
Sobhani P; Christopherson J; Ambrose PJ; Corelli RL
Ann Pharmacother; 2008 Jan; 42(1):46-52. PubMed ID: 18056832
[TBL] [Abstract][Full Text] [Related]
13. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
[TBL] [Abstract][Full Text] [Related]
14. A comparison of subcutaneous and intramuscular administration of human growth hormone in the therapy of growth hormone deficiency.
Russo L; Moore WV
J Clin Endocrinol Metab; 1982 Nov; 55(5):1003-6. PubMed ID: 6889608
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen).
Asakura T; Seino H; Nakano R; Muto T; Toraishi K; Sako Y; Kageyama M; Yohkoh N
Diabetes Technol Ther; 2009 Oct; 11(10):657-61. PubMed ID: 19821758
[TBL] [Abstract][Full Text] [Related]
16. Patient and Physician Perspectives on Mode of Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels.
Roth EM; Bujas-Bobanovic M; Louie MJ; Cariou B
Clin Ther; 2015 Sep; 37(9):1945-1954.e6. PubMed ID: 26278513
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone administration by means of an injection pen.
Jørgensen JO; Møller J; Jensen FS; Jørgensen JT; Christiansen JS
Pharmacol Toxicol; 1989 Aug; 65(2):96-9. PubMed ID: 2813289
[TBL] [Abstract][Full Text] [Related]
18. Nurses' perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting.
Shogbon AO; Ngo D; Jacob B; Kimble LP; Ryan G
Diabetes Technol Ther; 2014 Nov; 16(11):742-6. PubMed ID: 25198537
[TBL] [Abstract][Full Text] [Related]
19. Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes.
Gnanalingham MG; Newland P; Smith CP
Arch Dis Child; 1998 Jul; 79(1):59-62. PubMed ID: 9771255
[TBL] [Abstract][Full Text] [Related]
20. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
